scholarly article | Q13442814 |
P819 | ADS bibcode | 2015PLoSO..1015330Y |
P356 | DOI | 10.1371/JOURNAL.PONE.0115330 |
P932 | PMC publication ID | 4315393 |
P698 | PubMed publication ID | 25646897 |
P5875 | ResearchGate publication ID | 272082829 |
P2093 | author name string | Qun Wang | |
Jingjing Zhu | |||
Xiaowei Yang | |||
Hua-Chen Chang | |||
Baohua Zhou | |||
Chun-Yu Tung | |||
Gail Gardiner | |||
P2860 | cites work | Lunasin potentiates the effect of oxaliplatin preventing outgrowth of colon cancer metastasis, binds to α5β1 integrin and suppresses FAK/ERK/NF-κB signaling | Q39465105 |
Antioxidant and anti-inflammatory properties of cancer preventive peptide lunasin in RAW 264.7 macrophages. | Q39786576 | ||
Lunasin and lunasin-like peptides inhibit inflammation through suppression of NF-kappaB pathway in the macrophage | Q39812502 | ||
FIZZ1 plays a crucial role in early stage airway remodeling of OVA-induced asthma | Q39925363 | ||
Allergen-specific immunotherapy | Q40203811 | ||
Fibronectin induces cell proliferation and inhibits apoptosis in human bronchial epithelial cells: pro-oncogenic effects mediated by PI3-kinase and NF-kappa B. | Q40308412 | ||
Reversal of thymic stromal lymphopoietin-induced airway inflammation through inhibition of Th2 responses | Q40812554 | ||
DC-derived TSLP promotes Th2 polarization in LPS-primed allergic airway inflammation | Q40971237 | ||
Thymic stromal lymphopoietin interferes with airway tolerance by suppressing the generation of antigen-specific regulatory T cells | Q41832594 | ||
Soybean peptide lunasin suppresses in vitro and in vivo 7,12-dimethylbenz[a]anthracene-induced tumorigenesis | Q42741158 | ||
Crosstalk between T cells and bronchial fibroblasts obtained from asthmatic subjects involves CD40L/alpha 5 beta 1 interaction | Q43062632 | ||
IL‐10 and TGF‐β cooperate in the regulatory T cell response to mucosal allergens in normal immunity and specific immunotherapy | Q44429951 | ||
Antioxidant activity and protective effects of peptide lunasin against oxidative stress in intestinal Caco-2 cells. | Q46955927 | ||
Mechanisms of allergen-specific immunotherapy | Q59271653 | ||
NF-kappa B/Rel transcription factors: c-Rel promotes airway hyperresponsiveness and allergic pulmonary inflammation | Q73242714 | ||
Adaptive Foxp3+ regulatory T cell-dependent and -independent control of allergic inflammation | Q81617509 | ||
Chemopreventive property of a soybean peptide (lunasin) that binds to deacetylated histones and inhibits acetylation | Q28506766 | ||
Thymic stromal lymphopoietin as a key initiator of allergic airway inflammation in mice | Q28586460 | ||
CTLA-4 control over Foxp3+ regulatory T cell function | Q29619413 | ||
Presence of lunasin in plasma of men after soy protein consumption | Q30857865 | ||
Redox control of asthma: molecular mechanisms and therapeutic opportunities | Q33668491 | ||
MyD88-dependent induction of allergic Th2 responses to intranasal antigen. | Q33714813 | ||
A soybean cDNA encoding a chromatin-binding peptide inhibits mitosis of mammalian cells | Q33862461 | ||
Treatment of asthma and food allergy with herbal interventions from traditional chinese medicine | Q33987008 | ||
Amino acid sequence of a soybean (Glycine max) seed polypeptide having a poly(L-aspartic acid) structure | Q34185575 | ||
Grass pollen immunotherapy induces Foxp3-expressing CD4+ CD25+ cells in the nasal mucosa | Q34590830 | ||
Lung microbiota promotes tolerance to allergens in neonates via PD-L1. | Q35165937 | ||
Basis of CTLA-4 function in regulatory and conventional CD4(+) T cells | Q36014992 | ||
Extrathymically generated regulatory T cells control mucosal TH2 inflammation | Q36359813 | ||
Lipopolysaccharide-enhanced, toll-like receptor 4-dependent T helper cell type 2 responses to inhaled antigen | Q36376615 | ||
Essential role of nuclear factor kappaB in the induction of eosinophilia in allergic airway inflammation | Q36401739 | ||
Cutting edge: inhaled antigen upregulates retinaldehyde dehydrogenase in lung CD103+ but not plasmacytoid dendritic cells to induce Foxp3 de novo in CD4+ T cells and promote airway tolerance | Q36960928 | ||
Lunasin, a novel seed peptide for cancer prevention | Q37341231 | ||
Role of interleukin 10 in specific immunotherapy | Q37387064 | ||
Nuclear factor kappaB, airway epithelium, and asthma: avenues for redox control | Q37455687 | ||
Natural and adaptive foxp3+ regulatory T cells: more of the same or a division of labor? | Q37493607 | ||
Soypeptide lunasin in cytokine immunotherapy for lymphoma. | Q37592014 | ||
Innate and adaptive immune responses in asthma | Q38007827 | ||
Asthma phenotypes: the evolution from clinical to molecular approaches | Q38007831 | ||
Therapies for allergic inflammation: refining strategies to induce tolerance | Q38007833 | ||
Allergy immunotherapy: what is the evidence for cost saving? | Q38220852 | ||
RGD-peptide lunasin inhibits Akt-mediated NF-κB activation in human macrophages through interaction with the αVβ3 integrin | Q39285970 | ||
P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
P6216 | copyright status | copyrighted | Q50423863 |
P433 | issue | 2 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | e0115330 | |
P577 | publication date | 2015-02-03 | |
P1433 | published in | PLOS One | Q564954 |
P1476 | title | Lunasin alleviates allergic airway inflammation while increases antigen-specific Tregs | |
P478 | volume | 10 |